Dynamk Capital — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Xcell BiosciencesinJan 2022
BiotechSan Francisco, US
Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)
BoardSaeid Akhtari(Director)
Co-investorsCasdin CapitalFormic VenturesViking Global Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bionter AG
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.